Navigation Links
Statins Prescribed To Those Who Are At a Risk Of Developing A Heart Disease

In UK deaths due to heart disease is on the rise. Statistics show about 238000 people per year die due to heart problems//.

Hence The National Council for Health and Clinical Excellence (Nice) had asked the health officials to treat patients suffering from heart disease with statins.

It is estimate that about 3 million people suffer from 20% risk o developing a heart problem in the next 10 years.

The National Health Service (NHS) has asked the officials to put them on statin therapy. Statins are cholesterol-lowering drugs, which prevent the formation of low-density lipoprotein cholesterol, deposition of this cholesterol on the arteries (atherosclerosis) and risk of clot formation.

Already about 2 million people are under the statin therapy and Professor David Barnett of the Nice committee has planned to make it available it to another 3.3 million people.

The five different statin brands available in UK are atorvastatin, fluvastatin, pravastatin, rosuvastatin and simvastatin but only simvastatin, is available over the counter in pharmacies in a low 10mg dose.

The price of the drug is falling due to its growing demands. NHS is estimating the price to fall down to £9m.

According to the new guidelines Nice has asked the doctors to check the risk of developing a heart disease in patients who are above 40 years old.

Hence by making these drugs widely available it can cut down the risk of heart attacks, strokes and heart operations.
'"/>




Page: 1

Related medicine news :

1. Statins reduce heart attacks
2. Statins reduce risks for angioplasty patients
3. Statins Found To Be Helpful For Patients With Arthritis
4. Long-Term Benefits Of Statins Questioned
5. Statins Not Effective In Treating Calcific Aortic Stenosis
6. Statins Gives New Hope for Increased Survival Rate of Heart Failure Patients
7. The Effects of Statins Questioned
8. Statins Taken For Reducing Cholesterol Found To Reduce Death Rate Associated With Heart Attack As Well
9. Study Finds No Link Between Statins And Breast Cancer Risk
10. Statins Reduce Deaths And Strokes After Carotid Surgery
11. Statins reduces cardiovascular risk but no cancer risk.
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/24/2017)... ... April 24, 2017 , ... Labs often perform the ... for lab operators and management to assess these processes with a critical eye—particularly ... unnecessary actions. , Created with the help of both internal and external ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... clearly shows that over the last decade, student well-being has seriously declined. "When ... boxes of formal education, join the Islamic State to turn the historic multi-ethnic ...
(Date:4/24/2017)... ... April 24, 2017 , ... “Learning to Use Your SPIRITUAL ... “Learning to Use Your SPIRITUAL COMPASS To Navigate Life Issues” is the creation ... former Chairman of the Board of Directors for CONTACT USA, and former member of ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... Gallardo, DDS, PA will be attending the 2017 Oral Reconstruction Foundation’s 2017 Symposium ... , The Oral Reconstruction Foundation will present its annual Global Symposium at the ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... brands, work wear distributors and International relief organizations across the globe to provide ... also offers lifestyle and work wear collections via insectshield.com . In the ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)...  AbbVie (NYSE: ABBV), a global biopharmaceutical company, ... hepatitis C virus (HCV) infected patients with genotype ... cirrhosis (Child-Pugh A) achieved sustained virologic response at ... investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high ... weeks of G/P treatment without ribavirin. Patients with ...
(Date:4/20/2017)... Sweden , April 20, 2017 ... NEVPF) ("NeuroVive") today announced positive preclinical results ... preclinical compound for non-alcoholic steatohepatitis (NASH), in ... NV556 has previously shown ... NASH model. Today, NeuroVive,s scientists present novel ...
(Date:4/19/2017)... YORK , April 19, 2017 Cardiology devices ... the projected period The Cardiology Devices segment is ... than US$ 15 Mn in 2018 over 2017. By the ... a market valuation close to US$ 700 Mn, expanding at ... Devices segment dominated the Asia Pacific ...
Breaking Medicine Technology: